These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3316962)

  • 21. Association of inv(3)(q21q26) with essential thrombocythemia in transformation.
    Villalón C; Talavera M; Sordo MT; García-Sagredo JM; Lopez J; San Román C; Ferro MT
    Cancer Genet Cytogenet; 2008 Jul; 184(2):122-3. PubMed ID: 18617063
    [No Abstract]   [Full Text] [Related]  

  • 22. Asymptomatic essential thrombocythemia: a case report.
    Kapoor M; Misra V; Singh M; Mehrotra R; Dwivedi M
    Indian J Pathol Microbiol; 2003 Oct; 46(4):655-7. PubMed ID: 15025370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system granulocytic sarcoma in a patient with essential thrombocythemia.
    Grande M
    Am J Hematol; 1996 Jan; 51(1):64-7. PubMed ID: 8571939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Familial myeloproliferative syndrome].
    Tatti V; Marfurt P; Sirchia G; Pescia G; Luscieti P; Losa G
    Schweiz Med Wochenschr; 1984 Feb; 114(6):196-204. PubMed ID: 6701501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL
    Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis.
    Gargallo P; Hagemeijer A; Vassallu P; Kornblihtt L; Heller P; Molinas F; Larripa I
    Cancer Genet Cytogenet; 2004 Oct; 154(1):72-6. PubMed ID: 15381377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM; Thiele J
    Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomal banding pattern in the Guérin T8 ascite of the rat.
    Georgian L; Moraru I; Comişel V
    Morphol Embryol (Bucur); 1977; 23(4):293-6. PubMed ID: 144240
    [No Abstract]   [Full Text] [Related]  

  • 31. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
    Florena AM; Tripodo C; Iannitto E; Porcasi R; Ingrao S; Franco V
    Haematologica; 2004 Aug; 89(8):911-9. PubMed ID: 15339673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary and primary thrombocythemia].
    Judkiewicz L
    Acta Haematol Pol; 1993; 24(2 Suppl 1):15-20. PubMed ID: 8362612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Priapsim caused by primary thrombocythemia.
    Leifer W; Leifer G
    J Urol; 1979 Feb; 121(2):254-5. PubMed ID: 570610
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosomal abnormalities in essential thrombocythemia.
    Emilia G; Torelli G; Sacchi S; Donelli A
    Cancer Genet Cytogenet; 1985 Sep; 18(1):91-3. PubMed ID: 4040804
    [No Abstract]   [Full Text] [Related]  

  • 36. Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic/megakaryoblastic phenotypes.
    Frei-Lahr D; Barton JC; Hoffman R; Burkett LL; Prchal JT
    Blood; 1984 Apr; 63(4):866-72. PubMed ID: 6538450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic markers in essential thrombocythemia.
    Gale RE
    Curr Hematol Rep; 2003 May; 2(3):242-7. PubMed ID: 12901346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute myelofibrosis--case reports of acute megakaryoblastic leukemia and acute myeloblastic leukemia].
    Ishibashi T; Uchida T; Matsuda S; Sato T; Kimura H; Shichishima T; Mita M; Suzuki A; Kariyone S
    Rinsho Ketsueki; 1985 Jul; 26(7):1145-50. PubMed ID: 3863978
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic myelogenous leukemia with myelofibrosis. Four years after auto-immune hemolytic anemia.
    Cohen SM
    Arch Intern Med; 1967 Jun; 119(6):620-5. PubMed ID: 5229776
    [No Abstract]   [Full Text] [Related]  

  • 40. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.
    Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM
    Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.